Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04105010
Title Assessing An Oral Janus Kinase Inhibitor, AZD4205 as Monotherapy in Patients Who Have PTCL (JACKPOT8)
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Dizal Pharmaceuticals
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | AUS

Facility Status City State Zip Country Details
Yale Cancer Center New Haven Connecticut 06510 United States Details
Winship Cancer Institute Atlanta Georgia 30322 United States Details
Washington University School of Medicine Saint Louis Missouri 63110 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Epworth Hospital East Melbourne Australia Details
St Vincent's Hospital Melbourne Fitzroy Australia Details
Royal Hobart Hospital Hobart Australia Details
St George Hospital Kogarah Australia Details
Royal Perth Hospital Perth Australia Details
Westmead Hospital Westmead Australia Details
Beijing Cancer Hospital Beijing China Details
Beijing Friendship Hospital, Capital Medical University Beijing China Details
Beijing Hospital Beijing China Details
Peking University Third Hospital Beijing China Details
The First Hospital of Jilin University Changchun China Details
Hunan Cancer Hospital Changsha China Details
Xiangya Hospital Central South University Changsha China Details
Sichuan University - West China Hospital Chengdu China Details
Chongqing University Cancer Hospital Chongqing China Details
The Second Hospital of Dalian Medical University Dalian China Details
Guangdong Provincial People's Hospital Guangzhou China Details
NanFang Hospital of Southern Medical University Guangzhou China Details
Sun Yat-sen University Cancer Center Guangzhou China Details
Hainan General Hospital Haikou China Details
The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou China Details
Zhejiang Cancer Hospital Hangzhou China Details
Anhui Provincial Cancer Hospital Hefei China Details
The Second Hospital of Anhui Medical University Hefei China Details
Shandong Cancer Hospital Jinan China Details
The First Hospital of Lanzhou University Lanzhou China Details
Linyi Cancer Hospital Linyi China Details
Jiangxi Province Cancer Hospital Nanchang China Details
The First Affiliated Hospital of Nanchang University Nanchang China Details
Jiangsu Cancer Hospital Nanjing China Details
Fudan University Shanghai Cancer Center Shanghai China Details
Ruijin Hospital Shanghai Jiaotong University School of Medicine Shanghai China Details
The First Affiliated Hospital of Soochow University Suzhou China Details
Tianjin Medical University Cancer Institute and Hospital Tianjin China Details
Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan China Details
The First Affiliated Hospital of Xiamen University Xiamen China Details
Henan Cancer Hospital Zhengzhou China Details
Inje University Busan Paik Hospital Busan Korea, Republic of Details
Pusan National University Hospital Busan Korea, Republic of Details
Keimyung University Dongsan Hospital Daegu Korea, Republic of Details
National Cancer Center Goyang Korea, Republic of Details
Chonbuk National University Hospital Jeonju Korea, Republic of Details
Seoul National University Bundang Hospital Seongnam Korea, Republic of Details
Samsung Medical Center Seoul 06133 Korea, Republic of Details
Asan Medical Center Seoul Korea, Republic of Details
Seoul National University Hospital Seoul Korea, Republic of Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field